Scholarlink

Background <p>Poor self-reported sleep quality is associated with cognitive impairment. Alzheimer’s disease (AD) patients present sleep disruptions decades before they start to decline clinically. Similarly, amyloid-β (Aβ) starts accumulating during the preclinical phase of the disease. This study investigated associations between self-reported sleep quality and Aβ burden longitudinally in clinically unimpaired (CU) adults.</p> Methods <p>Four hundred seventeen CU adults from the AMYPAD PNHS cohort were included, with baseline self-reported sleep quality assessments (Pittsburgh Sleep Quality Index, PSQI) and longitudinal Aβ PET scans. Participants were categorized by baseline Aβ levels as negative (A-), grey-zone (GZ), or positive (A+). Linear mixed-effects (LME) models tested the association between baseline sleep quality and Aβ burden over time, including interaction effects with baseline Aβ status.</p> Results <p>Global PSQI score was not associated with Aβ burden over time in the entire group. However, a significant interaction with baseline Aβ status was found, whereby poorer subjective sleep quality was linked to accelerated Aβ accumulation in GZ participants.</p> Conclusions <p>Poorer subjective sleep quality is associated with faster Aβ accumulation in CU individuals with intermediate Aβ levels, highlighting sleep as a potential target for early AD prevention and identifying an optimal intervention window.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月17日

查看全文
  • Núria Tort-Colet,
  • Laura Stankeviciute,
  • Ana Fernández-Arcos,
  • Natalia Soldevila-Domenech,
  • Gonzalo Sánchez-Benavides,
  • Mahnaz Shekari,
  • David Vállez García,
  • Daniele Altomare,
  • Frederik Barkhof,
  • Mercè Boada,
  • Christopher Buckley,
  • Lyduine E. Collij,
  • Anouk den Braber,
  • Gill Farrar,
  • Lisa Ford,
  • Giovanni B. Frisoni,
  • Rossella Gismondi,
  • Juan D. Gispert,
  • Sylke Grootoonk,
  • Bernard J. Hanseeuw,
  • Frank Jessen,
  • Emma S. Luckett,
  • Richard Manber,
  • Marta Marquié,
  • Anja Mett,
  • Lisa Quenon,
  • Craig Ritchie,
  • Mark E. Schmidt,
  • Michael Schöll,
  • Andrew W. Stephens,
  • Rik Vandenberghe,
  • Pieter J. Visser,
  • Robin Wolz,
  • Oriol Grau-Rivera

摘要

Background

Poor self-reported sleep quality is associated with cognitive impairment. Alzheimer’s disease (AD) patients present sleep disruptions decades before they start to decline clinically. Similarly, amyloid-β (Aβ) starts accumulating during the preclinical phase of the disease. This study investigated associations between self-reported sleep quality and Aβ burden longitudinally in clinically unimpaired (CU) adults.

Methods

Four hundred seventeen CU adults from the AMYPAD PNHS cohort were included, with baseline self-reported sleep quality assessments (Pittsburgh Sleep Quality Index, PSQI) and longitudinal Aβ PET scans. Participants were categorized by baseline Aβ levels as negative (A-), grey-zone (GZ), or positive (A+). Linear mixed-effects (LME) models tested the association between baseline sleep quality and Aβ burden over time, including interaction effects with baseline Aβ status.

Results

Global PSQI score was not associated with Aβ burden over time in the entire group. However, a significant interaction with baseline Aβ status was found, whereby poorer subjective sleep quality was linked to accelerated Aβ accumulation in GZ participants.

Conclusions

Poorer subjective sleep quality is associated with faster Aβ accumulation in CU individuals with intermediate Aβ levels, highlighting sleep as a potential target for early AD prevention and identifying an optimal intervention window.